Technical Data
V2110-16Y
VEGFR1, Recombinant, Human (Vascular Endothelial Growth Factor Receptor 1, VEGFR-1, Fms-like Tyrosine Kinase 1, FLT-1, Tyrosine-protein Kinase FRT, Tyrosine-protein Kinase Receptor FLT, Vascular Permeability Factor Receptor, FLT1, FLT, FRT)
10ug
Growth Factors, Cytokines Storage: -20CShipping: Blue Ice
VEGFR-1 belongs to a family of five receptor tyrosine kinase receptors that are specific to a number of angiogenic factors including VEGF and PDGF, and are therefore thought to play a role in the angiogenic process. VEGFR-1 is expressed in two forms, predominantly on endothelial cells, giving rise to a full-length membrane bound receptor and a truncated soluble receptor. Elevated levels of the soluble form of this VEGF receptor may be used in the diagnosis of pathological conditions.

Source:
Recombinant corresponding to aa31-328 from human VEGFR, fused to 6x His-tag at N-terminal, expressed in E. coli.

Applications:
Suitable for use in Western Blot as a control. Other applications not tested.

Recommended Dilution:
Optimal dilutions to be determined by the researcher.

Storage and Stability:
May be stored at 4C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.
Source: E. coli
Purity: Purified (SDS-PAGE).
Concentration: As reported
Form: Supplied as a liquid in 25mM Tris-HCl, pH6.8, 50mM DTT, 1% SDS, 0.1% Bromophenol Blue, 2.5% glycerol.

Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications without the expressed written authorization of United States Biological.
1. Starovasnik, M. A et al. (1999) J. Mol. Biol. 296 (3): 531- 544. 2. Kanno, S. et al. (2000) Oncogene 19 (17): 2138-2146.

Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.